Medicare Enrolled
Dr. Craig Sclar, M.D.
Optician · San Diego, CA
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sclar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sclar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sclar
Dr. Craig Sclar is an optician specialist in San Diego, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sclar performed 1,785 Medicare services across 1,083 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sclar received a total of $7,613 from 64 pharmaceutical and/or device companies across 386 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sclar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 39% volume in CA
$7,613 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,785
Medicare services
Top 39% in CA for optician
1,083
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~94 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
841 | $6 | $36 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
203 | $67 | $141 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
96 | $65 | $180 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
92 | $46 | $79 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
74 | $11 | $33 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
67 | $84 | $210 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
65 | $1 | $50 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
61 | $41 | $92 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
57 | $159 | $700 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
40 | $55 | $230 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
38 | $11 | $98 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
35 | $107 | $351 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
34 | $387 | $942 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
31 | $72 | $210 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
23 | $143 | $409 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
15 | $8 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $101 | $212 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.8% high complexity
17.2% medium
76.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,613
Total received (2018-2024)
Avg $1,088/year across 7 years
Top 17% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
386
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,613 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,197
2023
$1,020
2022
$793
2021
$901
2020
$1,043
2019
$1,001
2018
$1,659
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$159
GlaxoSmithKline, LLC.
$147
Medtronic, Inc.
$130
Novo Nordisk Inc
$106
Novartis Pharmaceuticals Corporation
$71
ATRICURE, INC.
$59
Daiichi Sankyo Inc.
$56
Otsuka America Pharmaceutical, Inc.
$56
PFIZER INC.
$53
Hologic Sales and Service, LLC
$53
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$47
Antares Pharma, Inc.
$44
ABBVIE INC.
$32
Exact Sciences Corporation
$31
AstraZeneca Pharmaceuticals LP
$28
Boston Scientific Corporation
$24
SANOFI-AVENTIS U.S. LLC
$22
Amgen Inc.
$21
Phathom Pharmaceuticals, Inc.
$20
Astellas Pharma US Inc
$19
Bayer Healthcare Pharmaceuticals Inc.
$15
Top 3 companies account for 36.5% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$827
GlaxoSmithKline, LLC.
$732
AstraZeneca Pharmaceuticals LP
$656
Novo Nordisk Inc
$576
Lilly USA, LLC
$446
PFIZER INC.
$370
Janssen Pharmaceuticals, Inc
$354
Boehringer Ingelheim Pharmaceuticals, Inc.
$329
SANOFI-AVENTIS U.S. LLC
$261
Novartis Pharmaceuticals Corporation
$237
Merck Sharp & Dohme Corporation
$227
Boston Scientific Corporation
$223
Regeneron Healthcare Solutions, Inc.
$140
Medtronic, Inc.
$130
Teva Pharmaceuticals USA, Inc.
$125
AbbVie Inc.
$122
Allergan Inc.
$101
Antares Pharma, Inc.
$89
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$88
NOVARTIS PHARMACEUTICALS CORPORATION
$79
Lantheus Medical Imaging, Inc.
$78
Hologic Sales and Service, LLC
$71
Bayer HealthCare Pharmaceuticals Inc.
$71
E.R. Squibb & Sons, L.L.C.
$69
Bayer Healthcare Pharmaceuticals Inc.
$66
Allergan, Inc.
$60
ATRICURE, INC.
$59
Daiichi Sankyo Inc.
$56
Otsuka America Pharmaceutical, Inc.
$56
Takeda Pharmaceuticals U.S.A., Inc.
$51
Aytu BioScience, Inc
$48
Abbott Laboratories
$48
AbbVie, Inc.
$42
Actelion Pharmaceuticals US, Inc.
$42
Neurocrine Biosciences, Inc.
$41
Becton, Dickinson and Company
$40
Eisai Inc.
$40
Astellas Pharma US Inc
$39
Radius Health, Inc.
$38
JAZZ PHARMACEUTICALS INC.
$35
ABBVIE INC.
$32
Exact Sciences Corporation
$31
Organon LLC
$30
Insulet Corporation
$23
SANOFI PASTEUR INC.
$23
VBI Vaccines (Delaware) Inc.
$22
Baxter Healthcare
$20
Phathom Pharmaceuticals, Inc.
$20
Supernus Pharmaceuticals, Inc.
$20
Biohaven Pharmaceuticals, Inc.
$20
Biohaven Pharmaceutical Holding Company Ltd.
$19
Zealand Pharma US, Inc.
$18
Sanofi Pasteur Inc.
$18
INSYS Therapeutics Inc
$17
Kiniksa Pharmaceuticals, Ltd.
$15
Gilead Sciences, Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$15
Genentech USA, Inc.
$14
Optos, Inc.
$14
DERMIRA, INC.
$14
Seqirus USA Inc
$13
Xeris Pharmaceuticals, Inc.
$13
Medtronic USA, Inc.
$13
SI-BONE, INC.
$12
Top 3 companies account for 29.1% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · AJOVY · ANORO ELLIPTA · APTIMA · AREXVY · ATRICLIP LAA EXCLUSION SYSTEM · AUSTEDO · Aimovig · Arcalyst · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BREO · BREZTRI · CHANTIX · Cologuard Collection Kit · Creon · Dayvigo · Definity · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FORTEO · Fluad Quadrivalent · GENERAL - PAIN MANAGEMENT · GVOKE PFS · Hillrom - Cardiac Ambulatory Monitor · IFUSE IMPLANT · INGREZZA · INJECTAFER · INTELLIS · INTELLIS ADAPTIVESTIM · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINQ II · LINZESS · MOUNJARO · MitraClip System · NEXPLANON · NO PRODUCT DISCUSSED · NOCDURNA · NURTEC ODT · Natesto · OCTRODE · Omnipod · Otezla · Ozempic · P200DTx · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PreHevbrio · Prolia · QBREXZA · REXULTI · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · SYNDROS · SYNTHROID · Saxenda · Synthroid · TEZSPIRE · THINPREP 2000 PROCESSOR · TLANDO · TOUJEO · TRELEGY ELLIPTA · TRULICITY · TZIELD · Tresiba · Trintellix · Tymlos · UBRELVY · UPTRAVI · V-GO · VOQUEZNA · VRAYLAR · Veozah · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · XIFAXAN · XYOSTED · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
437
Per 100K population
13.3
County median income
$102,285
Nearest hospital
SHARP MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sclar is a cardiac imaging specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sclar experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Sclar performed 841 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sclar receive payments from pharmaceutical companies?
Yes. Dr. Sclar received a total of $7,613 from 64 companies across 386 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sclar's costs compare to other opticians in San Diego?
Dr. Sclar's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sclar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in San Diego
Browse opticians in San Diego ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology